Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TAZEMETOSTAT HYDROBROMIDE: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

50.4%
Female
49.6%
Male

Age Information

The average age of patients reporting adverse events with TAZEMETOSTAT HYDROBROMIDE is 54.0 years.

Geographic Distribution

The majority of adverse event reports for TAZEMETOSTAT HYDROBROMIDE originate from US.

Report Summary & Outcomes

1,323
Total Reports
1,323
As Primary/Secondary Suspect
158
Deaths Reported
233
Hospitalizations
10
Life-Threatening
1
Disabilities

Reporting Timeline

First adverse event report: 20080101. Most recent report: 20250918. View full timeline →

More About TAZEMETOSTAT HYDROBROMIDE

TAZEMETOSTAT HYDROBROMIDE Full Profile Reports by Year Drug Interactions